登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRixv，2月10日，（第2版更新）Transmission and epidemiological characteristics of Novel Coronavirus (2019-nCoV)-Infected Pneumonia(NCIP):preliminary evidence obtained in comparison with 2003-SARS》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-11

  • Transmission and epidemiological characteristics of Novel Coronavirus (2019-nCoV)-Infected Pneumonia(NCIP):preliminary evidence obtained in comparison with 2003-SARS

    Rongqiang Zhang, Hui Liu, Fengying Li, Bei Zhang, Qiling Liu, Xiangwen Li, Limei Luo

    doi: https://doi.org/10.1101/2020.01.30.20019836

    Abstract

    [Abstract] Objectives Latest epidemic information of Novel Coronavirus (2019-nCoV)-Infected Pneumonia (NCIP) was collected and a detailed statistical analysis was carried out to make comparison with 2003-SARS in order to provide scientific reference for the prevention and control of 2019-nCoV. Methods The information of NCIP and 2003-SARS from websites of NHCPRC and the World Health Organization was collected, and then the transmission dynamics of the two kinds of infectious diseases were analyzed. The information of 287 confirmed NCIP patients obtained from the website of health committees of 16 provinces. A descriptive epidemiological analysis method was employed to carefully analyze the epidemic characteristics. Subsequently, the NCIP epidemic data in Wuhan and other inland regions of China was analyzed separately and compared. A multivariate function model was constructed based on the confirmed NCIP case data. Results The growth rate of new cases and deaths of NCIP were significantly faster than those of 2003-SARS. The number of confirmed cases in Wuhan and other inland areas both showed increasing trends. 287 confirmed NCIP cases aged 9 months to 90 years and the average age was (42.38 ±15.97) years. The gender ratio (M: F) was 1.35: 1. The numbers of NCIP patients in Wuhan and other inland areas were in line with Y=0.7209 x3-11.97x2+59.129x (R2=0.9858) and Y=2.2169 x3-39.74x2+158.88x (R2=0.9357)，respectively, with good fitting effects judging by their R2 values. Conclusions The fatality rate of NCIP is lower than that of 2003-SARS and the cure rate is higher. The age of NCIP patients is mainly concentrated in the 30-50 years old (68.29%). The harm of the first-generation NCIP patients is indeed higher than that of secondary cases.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.01.30.20019836v2
50浏览量
原文链接
相关报告

  • 《BioRxiv，2月5日，（第2版更新）Genomic variance of the 2019-nCoV coronavirus》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-06
    • Genomic variance of the 2019-nCoV coronavirus Carmine Ceraolo, View ORCID ProfileFederico M Giorgi doi: https://doi.org/10.1101/2020.02.02.931162 Abstract There is rising global concern for the recently emerged novel Coronavirus (2019-nCov). Full genomic sequences have been released by the worldwide scientific community in the last few weeks in order to understand the evolutionary origin and molecular characteristics of this virus. Taking advantage of all the genomic information currently available, we constructed a phylogenetic tree including also representatives of other coronaviridae, such as Bat coronavirus (BCoV) and SARS. We confirm high sequence similarity (>99%) between all sequenced 2019-nCoVs genomes available, with the closest BCoV sequence sharing 96.2% sequence identity, confirming the notion of a zoonotic origin of 2019-nCoV. Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hyper-variable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein. Finally, we perform a full proteomic comparison with other coronaviridae, identifying key aminoacidic differences to be considered for antiviral strategies deriving from previous anti-coronavirus approaches. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    58浏览量
    原文链接

  • 《MedRxiv，2月17日，Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected Pneumonia (COVID-19): preliminary 》
    • 来源专题：COVID-19科研动态监测
    • 编译者：dingxq
    • 发布时间：2020-02-18
    • Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected Pneumonia (COVID-19): preliminary evidence obtained in comparison with 2003-SARS Rongqiang Zhang, Hui Liu, Fengying Li, Bei Zhang, Qiling Liu, Xiangwen Li, Limei Luo doi: https://doi.org/10.1101/2020.01.30.20019836 Abstract Objectives: Latest epidemic data of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected Pneumonia (COVID-19) was collected and a detailed statistical analysis was carried out to make comparison with 2003-SARS in order to provide scientific reference for the prevention and control of COVID-19. Methods: The information of COVID-19 and 2003-SARS from websites of NHCPRC and the World Health Organization was collected, and then the transmission dynamics of the two kinds of infectious diseases were analyzed. The information of 853 confirmed COVID-19 patients obtained from the website of health committees of 18 provinces. A descriptive epidemiological analysis method was employed to carefully analyze the epidemic characteristics. Subsequently, the COVID-19 epidemic data in Wuhan and other inland regions of China was analyzed separately and compared. A multivariate function model was constructed based on the confirmed COVID-19 case data. Results: The growth rate of new cases and deaths of COVID-19 were significantly faster than those of 2003-SARS. The number of confirmed cases in Wuhan and other inland areas both showed increasing trends. 853 confirmed COVID-19 cases aged 1 months to 94 years and the average age was (45.05 ± 17.22) years. The gender ratio (M: F) was 1.12: 1. Conclusions: The fatality rate of COVID-19 is lower than that of 2003-SARS and the cure rate is higher. The age of COVID-19 patients is mainly concentrated in the 30-50 years old (60.61%). The harm of the first-generation COVID-19 patients is higher than that of secondary cases. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    84浏览量
    原文链接